A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications. - Pozo-Rosich, Patricia; López, José Antonio Gien; Lisewski, Pawel; Aslan, Ayşe Neslihan; Seehra, Harpreet; Thiry, Alexandra; Abraham, Lucy; Ramirez, Luz M.; Fountaine, Robert; Fullerton, Terence (Cephalalgia, 2025)